CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $177,048
- in 4 filings
Net −$177,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | McKune John INTERIM CFO | Sale | −669 | $9.06 | $6K | 47,410 |
| 2024-03-01 | McKune John INTERIM CFO | Grant or award | +14,400 | 61,810 | ||
| 2024-03-01 | McKune John INTERIM CFO | Grant or award · Employee Stock Option (right to buy) | +28,800 | 28,800 | ||
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −459 | $9.06 | $4K | 149,380 |
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −809 | $9.06 | $7K | 148,571 |
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Sale | −3,083 | $9.06 | $28K | 145,488 |
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Grant or award | +34,500 | 179,988 | ||
| 2024-03-01 | Lehman David Aaron GENERAL COUNSEL | Grant or award · Employee Stock Option (right to buy) | +69,100 | 69,100 | ||
| 2024-03-01 | French Glendon E. III PRESIDENT AND CEO | Sale | −1,189 | $9.06 | $11K | 1,122,523 |
| 2024-03-01 | French Glendon E. III PRESIDENT AND CEO | Sale | −1,818 | $9.06 | $16K | 1,120,705 |
| 2024-03-01 | French Glendon E. III PRESIDENT AND CEO | Sale | −3,947 | $9.06 | $36K | 1,116,758 |
| 2024-02-22 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,184 | $14.20 | $17K | 243,049 |
| 2024-02-15 | French Glendon E. III PRESIDENT AND CEO | Sale 10b5-1 | −20,000 | $14.60 | $292K | 1,121,344 |
| 2024-01-22 | Rose Geoffrey Beran CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,184 | $13.13 | $16K | 244,233 |
| 2024-01-18 | French Glendon E. III PRESIDENT AND CEO | Sale 10b5-1 | −10,000 | $12.77 | $128K | 1,141,344 |
| 2023-12-22 | Rose Geoffrey Beran Chief Commercial Officer | Sale 10b5-1 | −1,184 | $12.75 | $15K | 245,417 |
| 2023-12-21 | French Glendon E. III President and CEO | Sale 10b5-1 | −10,000 | $12.42 | $124K | 1,151,344 |
| 2023-12-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −396 | $10.34 | $4K | 249,073 |
| 2023-12-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −698 | $10.34 | $7K | 248,375 |
| 2023-12-01 | Rose Geoffrey Beran Chief Commercial Officer | Sale | −1,774 | $10.34 | $18K | 246,601 |
Page 10 of 12 · 235 trades